Registration - In-house Corporation

Subject Matters

• Consumer Issues
• Government Procurement
• Health
• Industry
• Intellectual Property
• International Relations
• International Trade
• Regional Development
• Research and Development
• Science and Technology
• Taxation and Finance

Subject Matter Details

Grant, Contribution or Other Financial Benefit

• National Immunization Strategy. Advocacy to seek continued funding in vaccines.

Legislative Proposal, Bill or Resolution, Policies or Program, Regulation

• Health Canada's Consultation on fee proposal for drugs and medical devices
• The international trade negotiations under the North American Free Trade Agreement as it relates to potential legislative or regulatory changes of Canada's intellectual property regime for pharmaceutical products (Patent Act); Regulatory harmonization; the outdated supply chain regulations; pricing; cross-border trade; and confidential business information.

Legislative Proposal, Bill or Resolution, Regulation

• Patent Act as it relates to the implementation of the Comprehensive Economic Trade Agreement (CETA) and its Intellectual property protection provisions.

Policies or Program

• Federal Public Drug Plans, with respect to the reimbursement of therapeutic products for Federal plan beneficiaries
• Health Canada’s policies, program and guidelines related to the management, prevention, mitigation and notification of drug shortages
• Patented Medicine Prices Review Board (PMPRB)consultation on the proposed modernization of the Compendium of Policies, Guidelines and Procedures
• The Department of Innovation, Science and Economic Development consultation on the new Innovation Agenda: policy or program initiatives to support life science Research and Development conducted in Canada

Policies or Program, Regulation

• Regulations, policies and programs related to the reimbursement recommendations decision-making process and framework done by the Canadian Agency for Drugs and Technologies in Health (CADTH)/Common Drug Review as well as the review times and processes conducted by Health Canada for the purpuse of obtaining a notice of compliance.
• Subsequent Entry Biologics (SEBs) and Orphan Drugs framework: seeking an approval framework supported and protected by Regulations in harmonization with other developed countries

Regulation

• Health Canada's consultation on the future of Regulation of Self-Care Products
• Proposed modernization of the Patented Medicines Prices Review Board (PMPRB) Regulations in the consultation document “Protecting Canadians from Excessive Drug Prices”

Communication Techniques

• Written communication
• Oral communication
• Grass-roots communication

Government Institutions

• Atlantic Canada Opportunities Agency (ACOA)
• Canada Economic Development for Quebec Regions
• Canada Revenue Agency (CRA)
• Canadian Institutes of Health Research (CIHR)
• Employment and Social Development Canada (ESDC)
• Finance Canada (FIN)
• Global Affairs Canada (GAC)
• Health Canada (HC)
• House of Commons
• Indigenous and Northern Affairs Canada
• Innovation, Science and Economic Development Canada (ISED)
• Justice Canada (JC)
• National Defence (DND)
• Patented Medicine Prices Review Board (PMPRB)
• Prime Minister's Office (PMO)
• Privy Council Office (PCO)
• Public Health Agency of Canada (PHAC)
• Public Services and Procurement Canada (PSPC)
• Senate of Canada
• Treasury Board Of Canada Secretariat (TBS)
• Veterans Affairs Canada (VAC)
• Western Economic Diversification Canada (WD)

Address:
17,300 TRANS-CANADA HIGHWAY
KIRKLAND, QC  H9J 2M5
Canada

Telephone number: 514-693-4563
Fax number: 514-426-6921  

Parent Company Information